Introduction
Mutations in human Adenomatous polyposis coli (APC), a tumor suppressor gene, predispose individuals to both familial and sporadic colorectal cancer (for a review see Polakis, 1997) . The APC gene encodes a large protein (311 kD) with several distinct motifs and binding sites for a number of proteins ( Figure 1a ). Cell lines with mutations in the APC gene show enhanced levels of b-catenin, which suggests negative regulation of the cellular levels of b-catenin by APC. b-catenin, a transducer of Wnt signaling, is a potential oncogene, enhanced activation of which is the cause of many dierent kinds of cancer, such as colon cancer, melanomas, ovarian cancer, medulloblastoma, prostate cancer, uterine cancer etc (Morin, 1999) . According to the current model of b-catenin regulation, APC forms a complex with b-catenin, which is then recruited for degradation by Axin/GSK-3b complex (Polakis, 1997 and . This complex formation allows b-catenin to be phosphorylated by GSK-3b and the phosphorylated b-catenin is the target of ubiquitin-mediated degradation pathway. Wnt signals stabilize b-catenin by inhibiting GSK-3b activity and activating PP2A, which dephosphorylates Axin (Willert et al., 1999) . b-catenin then forms a complex with LEF/TCF, which acts as a transcriptional activator of certain growth promoting genes.
We have taken a genetic approach to examine, in vivo, the interactions between APC, b-catenin and other components of Wnt signaling pathway. However, structure-function relationship studies of large multidomain proteins, such as APC, require simple model systems amenable to various kinds of genetic and in vivo biochemical analyses. We have chosen the fruit¯y Drosophila, which ful®ls such a requirement, as the genetic system to study APC. One of the approaches fast gaining wide acceptability is to directly express human proteins in¯ies. Such a gain-of-function genetic approach has been used not only to study function of human proteins related to diseases (Deshpande et al., 1997; Fossgreen et al., 1998; Rao and Zipursky, 1998; Yamaguchi et al., 1999) , but also to study diseases per se (Jackson et al., 1998; Warrick et al., 1998; Feany and Bender, 2000) . Transgenic¯ies expressing human proteins have also been used to identify additional components of genetic pathways and disease inhibitors by suppressor-enhancer screens (Jackson et al., 1998; Yamaguchi et al., 1999; Warrick et al., 1999) .
We therefore generated transgenic¯ies carrying either full-length hAPC and or its fragment bearing b-catenin binding domain. In addition, we obtained transgenic¯ies expressing dAPC1 (Drosophila homologue of hAPC) from S Hayashi and E Wieschaus (unpublished) for comparative studies. These transgenic¯ies were used to correlate biochemical interactions amongst APC, b-catenin and GSK-3b to their in vivo function. Consistent with its biochemical properties, targeted expression of either full-length hAPC or its truncated form negatively regulated the function of Armadillo, the Drosophila homologue of b-catenin.
This in turn resulted in the inhibition of Wingless (Wnt/Wg) signaling during¯y development and gave rise to phenotypes similar to those associated with loss of Wnt/Wg signaling in Drosophila. Using hAPCinduced eye phenotypes as the assay in a screen for genetic modi®ers of APC function, we identi®ed two new loci in Drosophila, which may modulate Wnt signaling. In addition, we show that at least one of the currently used anti-cancer drugs speci®cally inhibits Wnt signaling pathway when fed to¯ies.
Results

Expression of hAPC protein in Drosophila
We generated transgenic¯ies for the full-length hAPC (hAPC/FL) as well as for the b-catenin binding domain (hAPC/CBD) ( Figure 1a ; for details see Materials and methods). We employed the GAL4-UAS system (Brand and Perrimon, 1993) for targeted expression of hAPC constructs in dierent tissues during development and in a number of genetic backgrounds. Expression of hAPC in¯ies was con®rmed by both RNA in situ ( Figure 1b ) and antibody staining (Figure 1d ). Both the constructs gave comparable phenotypes, although levels of expression of hAPC/FL were lower than those of the hAPC/CBD. Accordingly, eects of hAPC/FL expression were less severe than hAPC/CBD. Wherever both hAPC/FL and hAPC/CBD gave comparable phenotypes, the term hAPC is used to refer to them together. All the ®gures show representative results with either hAPC/FL or hAPC/CBD or both.
Targeted expression of hAPC in Drosophila induced phenotypes that mimic loss of Wg
To determine if hAPC interferes with Wnt/Wg signaling in¯ies, its expression was targeted to Wgdependent developmental pathways. In Drosophila, Wnt/Wg signaling is functional in various tissues during both embryonic and post-embryonic stages of development. Events of particular interest here are (i) proper speci®cation of segmental boundaries in the embryonic and adult epidermis and (ii) growth and patterning during the development of legs, wings, antennae and eyes. Wg and Decapentaplegic (Dpp) are known to repress each other's expression during leg development (Morimura et al., 1996; Brook and Cohen, 1996) . The mutually antagonistic interactions between Wg and Dpp ensure the maintenance of their expression in spatially restricted domains. The combined action of these two genes activates Distal-less (Dll) in distal segments and Dacshund (Dac) in proximal segments Wu and Cohen, 1999) . Expression of hAPC in leg discs using ptc-GAL4 resulted in ectopic expression of Dpp (Figure 1g ), suggesting negative regulation of Wnt/ Wg signaling. Ectopic expression of Dll was also seen (Figure 1k,l) , which re¯ects altered expression patterns of Wg and Dpp (Brook and Cohen, 1996) . In addition, levels of Dac, another target of Wg (Wu and Cohen, 1999) , were reduced in anterior ventral quadrant followed by hAPC expression (Figure 1i ). In Drosophila, many genes are known to autoregulate their expression during development, wg being one of them (Hooper, 1994; Yoe et al., 1995) . For example, ectopic expression of activated Armadillo (b-catenin/ Arm) using dpp-GAL4 results in the activation of Wg in anterior-dorsal quadrant (Figure 1n ), which is otherwise normally expressed only in the ventral quadrant ( Figure 1m ). We observed a decrease in the levels of Wg expression followed by hAPC expression as monitored by both wg-lacZ (data not shown) and anti-Wg antibodies (Figure 1o ). Thus, all the molecular markers tested (Wg, Dpp, Dll and Dac) suggested down-regulation of Wg signaling in¯ies when hAPC was mis-expressed.
Adult¯ies expressing hAPC induced adult epidermal, leg, antennal and wing phenotypes, all of which resembled the phenotypes caused by loss of Wg. In the adult epidermis, the dorsal tergites were not properly developed and were devoid of pigmentation (Figure 2b ). Similar phenotypes have been reported for loss of wg function during pupal development (Shirras and Couso, 1996; Kopp et al., 1999) . In wing imaginal discs, Wnt/Wg signaling arising from the dorso-ventral (D/V) boundary regulates speci®cation of wing margin bristles and growth and patterning of the entire wing blade (Zecca et al., 1996; Neumann and Cohen, 1997) . Consistent with this function of Wg, we observed loss of wing margin and wing tissue in adult wings expressing hAPC (Figure 2d ± f). Adult¯ies expressing hAPC also exhibited leg phenotypes such as leg duplications (Figure 2h ± j) that were similar to the phenotypes induced by loss of Wg (Held et al., 1994) . In developing eye imaginal discs too, Wg negatively interacts with Dpp to regulate the morphogenetic furrow progression (Ma et al., 1993, Treisman and Rubin, 1995) . Expression of hAPC in the eye disc using ey-GAL4 resulted in inappropriate patterning of ommatidia, leading to either ectopic ommatidia in the anterior head capsule or in severe cases, loss of ommatidia (Figure 2k ,m,n; Figure 6 ). The phenotypes were identical to those induced by the overexpression of Dpp or activated form of its receptor Thick-vein (Figure 2l ), further suggesting down regulation of Wnt/Wg signaling by hAPC. When hAPC was expressed in the developing antennae, phenotypes such as duplication of aristae were observed in the antenna (Figure 2p ). Since the patterning events and the nature of Wg and Dpp interactions in developing antennae and legs are similar, such phenotypes are also attributable to perturbations in Wnt/Wg signaling (Diaz-Benjumea et al., 1994) .
Negative interactions between hAPC and b-catenin/Arm
Similar leg and eye phenotypes were also induced by the intra-cellular domain of Drosophila E-cadherin (UAS-CAD i5 ; Sanson et al., 1996) , which is known to deplete the cytoplasmic pool of b-catenin/Arm. Since APC is a known b-catenin-binding protein, it was hypothesized that hAPC-induced phenotypes were also mediated by the negative regulation of b-catenin/Arm. This was supported by the enhanced leg phenotypes (often leading to total loss of appendage development) induced by the expression of hAPC using ptc-GAL4 in ies heterozygous for a null mutation in arm (data not shown). In addition, hAPC could alleviate the eects of higher levels of b-catenin/Arm, when co-expressed with (H-J) hAPC-induced (expressed using ptc-GAL4) leg phenotypes. They include branched legs (arrow in H), duplication of claws (arrow in I) and sex-combs (arrow in j). (k ± m) hAPC-induced (expressed using ey-GAL4) eye phenotypes. Often, the eyes were protruding anteriorly due to ectopic ommatidia on the head capsule. However, the total number of ommatidia was often less than normal (k). hAPC also induced duplication of inter-ommatidial bristles (l,m; arrow in m). (l) Similar phenotype induced by the expression of activated TKV receptor using ey-GAL4. (n) Wildtype antenna. (o) hAPCinduced (expressed using ptc-GAL4) duplication of arista Flu-DArm (Zecca et al., 1996) , a stable form of bcatenin/Arm (Figure 3c ). Possibility of suppression of hAPC-induced phenotypes by the over-expression of bcatenin/Arm was also examined. Enhanced Wg activity in developing eye imaginal discs down-regulates Dpp causing inhibition of morphogenetic furrow progression, which in turn leads to loss of ommatidia (Treisman and Rubin, 1995) . Consistent with this, mis-expression of Flu-DArm using ey-GAL4 resulted in severe loss of ommatidia. Although hAPC ( Figure 1k ) and Flu-DArm ( Figure 3e ) induce eye abnormalities when expressed individually using ey-GAL4,¯ies expressing both had normal eyes ( Figure 3f ) (nearnormal eyes with hAPC/FL; data not shown). This suggests that, at least in the eye, hAPC-induced phenotypes were entirely due to its interaction with b-catenin/Arm.
However, no phenotype was observed when UASdAPC1 (S Hayashi and E Wieschaus, personal communication) or UAS-dAPC2 (or UAS-EAPC; M Bienz, personal communication) was crossed to various GAL4 lines. We generated additional insertions of UAS-dAPC1 by mobilizing one of the original transgenic insertions of UAS-dAPC1 (kindly provided by Shigemi Hayashi and Eric Wieschaus). We observed only very weak phenotypes when dAPC1 expressed using new insertion lines and various GAL4 lines at 298C (data not shown). Its ability to suppress the phenotypes induced by over-expression of dominant forms of b-catenin/Arm was also negligible. This can be attributed to lower levels of dAPC expression. Indeed, anti-APC antibody staining on imaginal discs expressing UAS-dAPC1 (driven by ptc-GAL4) showed marginal increase in the levels of dAPC1 along the A/P boundary (Figure 1e ; however, also see below).
Therefore, to further validate genetic studies on hAPC in this heterologous system, it was determined whether hAPC could be substituted for its Drosophila 
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Q8¯y . Note normal pigmentation and re-appearance of pseudopupil. Expression of hAPC/FL alone using 405-GAL4 did not induce any phenotype Human APC in transgenic Drosophila P Bhandari and LS Shashidhara homologue dAPC. In dAPC Q8 (an hypomorphic allele of dAPC) a small number of homozygous¯ies do emerge, all of which show increase in eye pigmentation and absence of pseudopupil (Figure 3i ), an indication of degeneration of retinal neurons (Ahmed et al., 1998) . hAPC/FL was expressed in dAPC Q8 /dAPC Q8 background with the help of 405-GAL4 driver, which is expressed in the dierentiating retinal neurons (Figure 3g ). Although there was no change in the viability of homozygous dAPC Q8
Q8¯i es (around 5%), all the¯ies expressing hAPC/FL in dAPC Q8 / dAPC Q8 background (n=11 in one representative experiment) showed the presence of pseudopupil and normal levels of eye pigmentation suggesting complementation of dAPC by hAPC/FL (Figure 3j ). Such rescue experiments with hAPC/CBD were not conclusive since, for some unknown reason, recombinants of hAPC/CBD and dAPC Q8 obtained on the 3rd chromosome were unstable.
Nevertheless, we have shown that hAPC-induced phenotypes in¯ies were consistent with the role of hAPC as a negative regulator of b-catenin/Arm activity thereby, supporting the use of a¯y model system for genetic analyses of hAPC function.
Sequestration of b-catenin/Arm by hAPC
We monitored changes in the levels of b-catenin/Arm following hAPC expression. Normally, b-catenin/Arm is present in all the cells, although its levels are slightly higher in cells where Wnt/Wg signaling is active (for example, in the wing disc D/V boundary; Figure 4g ). We observed enhanced levels of b-catenin/Arm in a subset of hAPC-expressing cells (Figure 4b,d,h,i) . In other cells, the levels of b-catenin/Arm were comparable to the wildtype levels. However, immunoprecipitation and Western blot analyses did not show any marked increase in the levels of b-catenin/Arm over the control (data not shown). This may be due to the fact that hAPC-mediated accumulation of bcatenin/Arm is seen only in a small fraction of cells (we extracted proteins from all imginal discs expressing hAPC for Western blotting).
Double staining for b-catenin/Arm and Wg revealed that b-catenin/Arm was accumulated in cells where hAPC and endogenous Wg expression overlapped (Figure 4l ). Wnt/Wg signaling inhibits the degradation of b-catenin/Arm by down regulating the activities of GSK-3b/Sgg and Axin (Willert et al., 1999) . Thus, our observations on the accumulation of b-catenin/Arm only in cells expressing both hAPC and endogenous Wg suggests that (i) hAPC could eciently inhibit the function of cytoplasmic b-catenin/Arm even in the cells where Shaggy/Zeste-White3 (GSK-3b/Sgg) activity is down regulated by Wnt/Wg signaling and (ii) hAPCinduced phenotypes were due to the sequestration of bcatenin/Arm. Since hAPC can eciently bind and sequester larger amounts of b-catenin/Arm in cells responding to Wnt/Wg signaling, we presume that in other cells too it can bind b-catenin/Arm. It implies that in those cells hAPC-bound form of b-catenin/Arm is recognized by the Axin-GSK-3b/Sgg complex for degradation. As expected, ectopic expression of UAS-CAD i5 using ptc-GAL4 driver resulted in the accumulation of large and equal amounts of b-catenin/Arm all along the A/P boundary, irrespective of the presence or absence of Wnt/Wg signaling (Figure 4j) .
We further examined the regulation of b-catenin/ Arm at the transcriptional level using arm-lacZ construct. There was no change in lacZ levels in response to hAPC expression in dierent tissues (data not shown). This suggests that hAPC-induced increase in the levels of b-catenin/Arm protein (Figure 4b,d ,h,i) was due to stabilization of hAPC/b-catenin/Arm complex by Wnt/Wg signaling (Papko et al., 1996) .
Binding of hAPC to b-catenin/Arm is independent of GSK-3b/Sgg activity We then studied the requirement of GSK-3b/Sgg activity for hAPC-mediated inhibition of b-catenin/ Arm function. hAPC and the degradation-resistant form of Arm (Flu-DArm or UAS-S10) were coexpressed in the wing disc D/V boundary using vg-GAL4. In the wing pouch, Wg is maximally expressed in the D/V boundary (Figure 4k ) and GSK3b/Sgg ) . In all the wing and leg discs shown in this ®gure, anterior is to the left and ventral is up Oncogene Human APC in transgenic Drosophila P Bhandari and LS Shashidhara activity is expected to be minimum. In addition, due to N-terminal deletions, Flu-DArm and UAS-S10 would not be phosphorylated by whatever the residual GSK3b is present (Zecca et al., 1996; Pai et al., 1997) . Both hAPC/FL and hAPC/CBD suppressed the phenotypes induced by Flu-DArm and UAS-S10 (data not shown) with the same eciency as it suppressed the ectopic bcatenin/Arm activity in a non-Wg region (Figure 3c,f) .
To further examine the requirement of GSK-3b/Sgg activity for the hAPC-mediated degradation of bcatenin/Arm, we expressed hAPC and/or GSK-3b/Sgg in wing imaginal discs using vg-GAL4 driver. We used only hAPC/CBD in this experiment since the increase in the levels of b-catenin/Arm following hAPC/FL expression was much lower than that induced by hAPC/CBD (compare Figure 4h,i) . Expression of hAPC/CBD using vg-GAL4 resulted in the accumulation of a large amount of b-catenin/Arm in the D/V boundary ( Figure 5b) . Whereas, over-expression of GSK-3b/Sgg alone or together with hAPC/CBD resulted in reduced b-catenin/Arm levels in the D/V boundary (Figure 5c,d ). This supports our earlier conclusion that hAPC could bind b-catenin/Arm in the presence or absence of GSK-3b/Sgg activity, although b-catenin/Arm is degraded only in cells where GSK-3b/Sgg is active. However, hAPC/CBD levels were not altered irrespective of the presence or absence of GSK-3b/Sgg activity (Figure 5e ,f).
Genetic enhancers of hAPC-induced phenotypes
We made use of transgenic¯ies expressing hAPC to identify new genes that are modulators or even components of the Wnt/Wg signaling pathway. We used alterations of APC-induced eye phenotypes as the assay system since eye phenotypes are easy to score. We crossed UAS-hAPC to ey-GAL4 in the presence of additional mutations in the genome (we tested only the 3rd chromosome mutations). We observed that a deletion in the polytene region 85F (uncovered by Df(3R)by62 and not by its overlapping de®ciency Df(3R)by10) enhanced the eye phenotypes induced by hAPC (particularly with hAPC/CBD) to such an extent that manȳ ies were totally eyeless ( Figure 6 ; Table 1 ). twins (tws) is one of the many genes mapped to 85F region (http:// ybase.bio.indiana.edu), which codes for the regulatory sub-unit of protein phosphatase 2A (PP2A). However, none of the three alleles of tws (P1568, tws 55 and tws
60
) that were tested enhanced hAPC-induced eye phenotypes. We also tried alleles of other neighboring genes such as Ras (Ras e1B ) and many of the available lethal P-insertions (P237, P1595, P1659 and P1783) mapping to 85F region (http://¯ybase.bio.indiana.edu). None enhanced the hAPC-induced eye phenotypes. This suggests the possibility of a hitherto unknown modulator of Wg signaling pathway in 85F region. Currently, additional mutation screens are being used to identify the gene.
In addition, mutations in l(3)67E2 (caused by the imprecise excision of a P-element insertion) also showed enhanced eye-phenotypes, although less severe when compared to Df(3R)by62 ( Figure 6 , Table 1 ). This is a novel gene being characterized in our laboratory and shows enhancement of phenotypes of certain Wg alleles such as Wg P and Spd¯g, Spd hL2 (R Bajpai and LS Shashidhara, unpublished observations).
Chemical enhancers of hAPC-induced phenotypes
We examined if transgenic¯ies expressing hAPC can be used for screening potential drugs against colon cancer. As pilot experiments, we used some of the known anti-colon cancer drugs for their eect on Drosophila. We used 5-¯uorouracil, pyroxicam, indomethacin, and aspirin (kindly provided by Dr Reddy's laboratories, Hyderabad). We ®rst determined LD50 for each of the chemicals tested (data not shown). At concentrations LD50 and below, none of the drugs induced any morphological phenotypes in wildtypē ies. We then tested their eect on transgenic¯ies expressing hAPC in developing eyes (using ey-GAL4). The rationale behind these tests is as follows. At higher concentrations a drug might aect viability, fertility and development of organisms due to physiological imbalance it may cause. However, at lower concentrations a drug may be ineective. If a drug is administered to¯ies, which are already sensitized by ) genetic manipulations, it may exhibit its speci®c eect even at lower concentrations. We observed that indomethacin enhanced hAPC-induced eye phenotypes to the extent similar to the enhancement shown by Df(3R)by62 ( Figure 6 and Table 1 ). The eect was concentration dependent, maximum being at 200 mg/ml of¯y food (LD50 being at 250 mg/ml of¯y food). Indomethacin is a non-steroid anti-in¯ammatory drug (NSAID) known to aect the transcription downstream of peroxisome proliferator activated receptortype d (PPARd; He et al., 1999) , a member of nuclear hormone receptors. We compared the protein sequence of PPARd to that of Drosophila proteins (known and predicted). Eip75B, a transcription factor in ecdysone response pathway, shows 38% identity and 59% homology to PPARd. However, Eip75B is 1443 amino acid-long, whereas PPARd is only 441 amino-acid long. Furthermore, we did not observe any enhancement of hAPC-induced eye phenotypes, when hAPC/ CBD was expressed using ey-GAL4 in the background of lethal mutation in Eip75B (Eip75B07041; http:// ybase.bio.indiana.edu). Currently work is in progress to identify the target for indomethacin in¯ies, which may also be a functional homologue of PPARd.
Targets of other three drugs tested here may not be within Wnt signaling pathway. This is particularly true for 5-¯uorouracil, which is known to aect DNA synthesis. Thus, our results show the potential use of transgenic¯ies in identifying targets (and thereby mode of action) of drugs that are already being used, which can be extended to screen for novel drugs.
Discussion
Considering the importance of Wnt signaling pathway in the contexts of development and tumor formation, it is important to identify additional components regulating this pathway. They provide useful tools for understanding the intricacies of the pathway and would also provide additional targets for drug screening. We have adopted a gain-of-function genetic approach to identify additional components of Wnt pathway by generating transgenic¯ies harboring hAPC constructs. During recent years there have been a number of reports in which¯y models have been used to study human genes and diseases (Deshpande et al., 1997; Fossgreen et al., 1998; Rao and Zipursky, 1998 Numbers in parenthesis in the last column indicates total number of¯ies of right genotype Figure 6 Enhancement of hAPC induced eye phenotypes in Drosophila by two independent deletion mutations in the third chromosome and by the non-steroid anti-in¯ammatory drug, indomethacin. Eye phenotypes are classi®ed in the order of severity from 1 to 20 and thus, these images represent phenotypes induced in all genetic backgrounds. hAPC/CBD in wildtype background induced phenotypes in the range of 1 ± 10 (1 ± 3 for hAPC/FL). Expression of hAPC/CBD in the presence of either Df(3R)by62 or l(3L)67E2 or the drug indomethacin showed much-enhanced phenotypes (ranging from 1 ± 20; 1 ± 12 for hAPC/ FL) often-resulting in eyeless¯ies. WT ± wild type eye Feany and Bender, 2000) . Nevertheless, before we attempt to use hAPC expressing transgenic ies in any study, it is important to ensure that its behavior in¯ies is consistent with its biochemical role in humans. We have shown that hAPC-induced phenotypes in¯ies were consistent with the role of hAPC as a negative regulator of b-catenin/Arm activity. Using various GAL4 drivers, we expressed hAPC in cells with either low or high levels of cytoplasmic b-catenin (which is dependent on the presence or absence of Wnt/Wg signaling). Our observations reveal that hAPC expression induced speci®c phenotypes, which mimic loss of Wg signaling. The down regulation of b-catenin/Arm activity in our experiments was not a mere re¯ection of the presence of an overwhelming amount of hAPC, since we have shown that hAPC could alleviate dominant phenotypes caused by the over-expression of b-catenin/Arm. In addition, suppression of hAPC-induced eye phenotype by over-expressed b-catenin/Arm strongly supports the conclusion that hAPC-induced phenotypes in¯ies are entirely due to the negative regulation of b-catenin/ Arm. These observations also suggest that hAPC expression in the heterologous system did not lead to any dominant-negative eect. Finally, loss-of-function mutations in dAPC were complemented by the overexpression of hAPC.
However, no phenotype was observed when UASdAPC1 (S Hayashi and E Wieschaus, personal communication; this report) or UAS-dAPC2 (or UAS-EAPC; M Bienz, personal communication) was crossed to various GAL4 lines. This is particularly intriguing considering the speci®city of hAPC-induced phenotypes in¯ies. One possible explanation is, not enough protein was made in the crosses with UASdAPC1 and UAS-EAPC. This we have observed to be true, at least, for dAPC1. An alternate hypothesis is that hAPC has higher anity for b-catenin/Arm than dAPC1 or EAPC. Considering the potential oncogenic activity of b-catenin, human APC may have evolved to bind with a higher anity to b-catenin than Drosophila APC binding to b-catenin/Arm. b-catenins are far more highly conserved (http://www.ncbi.nlm.nih.gov/ UniGene/clust.cgi?ORG=Hs&CID=171271) than APC (http://www.ncbi.nlm.nih.gov/UniGene/clust.cgi? ORG =Hs&CID=75081) across a number of species from Drosophila to human. In addition, all the three aminoacids (Arginine 386, Lysine 345 and Tryptophan 383 of human b-catenin; von Kries et al., 2000) in bcatenin that are critical for binding to APC are conserved between Drosophila and human b-catenins. hAPC, therefore, may have shown higher anity for bcatenin/Arm than dAPC itself.
Thus, the observation that expression of hAPC results in stronger phenotypes indicates the uniqueness of this transgenic system to study genetic and biochemical pathways related to Wnt/Wg function. The role of bcatenin/Arm in cell-adhesion has always been a limitation to generate loss-of-function clones of arm 7 cells to study Wnt/Wg signaling during post-embryonic stages. Such clones are invariably cell-lethal due to loss of celladhesion and do not produce any data on Wnt/Wg signaling events. Therefore, the development of a gainof-function genetic model for hAPC similar to the one described here, has certain advantages to study Wnt/Wg signaling in Drosophila itself.
Recently, it has been reported that all of the Cterminal domains of APC are dispensable in mouse. A mouse model homozygous for APC1638T, expressing a truncated protein with ability to bind b-catenin, is viable and tumor-free (Smits et al., 1999) . This was supported by the observation that expression of the bcatenin binding domain of hAPC alone was enough to down regulate b-catenin activity in colon cancer cell lines (Shih et al., 2000) . In the experiments described in this report too, hAPC/CBD alone was enough to bind and transport b-catenin to degradation zone and to subject the same for degradation in the presence of GSK-3b activity. It would be interesting to examine the role of other domains of APC in the contexts of development, particularly of colon.
It has been reported earlier that over-expression of Wnt-1 (which in turn inhibits GSK-3b activity) in mouse mammary epithelial or pituitary cell lines is known to cause increased stabilization of APC/bcatenin complex (Papko et al., 1996) . Similar stabilization of APC/b-catenin complex is observed in human cell lines expressing degradation-resistant forms of b-catenin Ilyas et al., 2000) . In our experiments too, hAPC was able to suppress with equal eciency b-catenin/Arm-induced dominant phenotypes in the presence as well as in the absence of GSK-3b/Sgg activity. The uncoupling of inhibition of b-catenin activity from its degradation suggests that hAPC inhibited Wnt/Wg signaling by sequestering bcatenin and not by the down regulation of its protein levels. We have also observed that hAPC itself is not degraded even in the cells over-expressing GSK-3b/Sgg. Since b-catenin is inactive when it is in APC-bound form (this report), its degradation may help the cells to reuse APC protein (Bienz, 1999) . Our results would also predict that abolition of Axin and APC interaction would reduce the availability of free APC to bind bcatenin, but would not completely inhibit APC activity. Indeed, colorectal cancers caused by mutations in APC that delete only the Axin binding sites show either attenuated polyposis or nonpolyposis phenotypes (Friedl et al., 1996; Scott et al., 1996) .
We further carried out a genetic screen to identify modi®ers of hAPC expressed in¯ies. Drosophila eye is one of the well-studied developmental systems and makes a powerful model system for deciphering the function of genes in biological processes (Thomas and Wassarman, 1999) . Our assay too was based on the modi®cation of APC-induced eye phenotypes. Any enhancement of this phenotype would suggest a genetic mutation, which down regulates Wnt signaling. The normal function of such a gene could be positive regulation of Wnt signaling and hence it would be a potential target for drug screening against colon cancer. We have identi®ed two such loci on the third chromosome, which enhance APC-induced phenotypes.
We are currently working to identify these genes and their role in the Wnt/Wg signaling pathway. In addition, in a series of experiments to validate some of the currently used anti-colon cancer drugs, we have con®rmed the presence of target(s) for indomethacin in the Drosophila Wnt/Wg pathway. Thus, in this report we have demonstrated the use of Drosophila in functional genomics and in screening for therapeutic drugs against cancer and other disease conditions caused by enhanced levels of b-catenin.
Materials and methods
Fly stocks and generation of transgenic flies
Full-length hAPC cDNA clone (Kinzler et al., 1991) was released from its vector (pCMV) by BamHI digestion. The 8.9 kb insert was sub-cloned into the P-element vector, pCaSpeR-UAS (Brand and Perrimon, 1993) . The b-catenin binding domain (amino-acids from 959 to 1870) was released from a partial cDNA clone of hAPC (FB10B; Kinzler et al., 1991) by EcoRI and XbaI digestion. The 2.7 kb fragment was independently sub-cloned into pCaSpeR-UAS. Both the constructs were injected into w; D2 ± 3 Ki embryos carrying a genetic source of transposase (Cooley et al., 1988) . We generated 15 independent transgenic lines for the full-length construct and 14 for the b-catenin binding domain. All the transgenic¯ies were crossed to various GAL4 drivers to express hAPC in dierent tissues. Hereafter, we refer to transgenic¯ies with full-length hAPC as hAPC/FL and those with the b-catenin binding domain alone as hAPC/CBD. The term hAPC is used to refer to them together, whenever both transgenes show similar phenotypes/results. UAS-dAPC was generated by S Hayashi and E Wieschaus using cDNA clone for dAPC1, the ®rst Drosophila homologue of APC. The Xchromosome insertion of UAS-dAPC was mobilized by crossing to a genetic source of transposase (w; D2 ± 3 Sb / D2 ± 3 TM2). As many as 15 new insertions were crossed to dierent GAL4 lines for further analysis.
Recombinant chromosomes and combinations of other UAS lines, dierent mutations and/or markers were made by standard genetic techniques. Other UAS lines used were, UAS-Flu-DArm (N-terminal 155 residues are deleted in this construct due to which over-expressed Arm is resistant to GSK-3b-mediated degradation, but can displace endogenous b-catenin/Arm from the adhesion complex; ref. Zecca et al., 1996) , UAS-S10 (another activated form of Arm resistant to GSK-3b-mediated degradation due to an internal deletion of N-terminal 43 ± 87 residues, but present both in the nucleus and cytoplasm; Pai et al., 1997) , UAS-Zw3 (GSK-3b/Sgg; Steitz et al., 1998) , UAS-Cad i5 (intracellular domain of Drosophila E-cadherin; Sanson et al., 1996) , UAS-Dpp (Frasch, 1995) and UAS-activated Tkv (Thickvein a receptor of Dpp; Nellen et al., 1994) . GAL4 strains used were ptc-and en-GAL4 (Brand and Perrimon, 1993) , dpp-GAL4 (Morimura et al., 1996) , ey-GAL4 (Hazelett et al., 1998 ), vg-GAL4 (Simmonds et al., 1995 , Actin5C4CD24GAL4 (Pignoni and Zipursky, 1997) and unpublished) . Choice of GAL4 drivers for the expression of hAPC and/or other proteins was mainly determined by the severity of the phenotype.
To examine the eect of lowering endogenous b-catenin/ Arm levels on hAPC induced phenotypes, arm 4 allele of arm (http://¯ybase.bio.indiana.edu) was used along with hAPC, wherein¯ies carrying one copy of hAPC and one copy of arm 4 allele were crossed to ptc-and dpp-GAL4 drivers. To rescue mutant phenotypes of dAPC, hAPC/FL was combined with dAPC Q8 (Ahmed et al., 1998) and the resultant¯ies were crossed to 405-GAL4 driver, which was also heterozygous for dAPC
Q8
. Homozygous¯ies were identi®ed with the help of ebony marker associated with dAPC
. To screen for genetic modi®ers of hAPC function, ey-GAL4 was ®rst crossed to a collection of Drosophila mutants (26 deletion mutations and 10 P-lethal insertions; all mapped to 3rd chromosome) and then to UAS-hAPC/CBD.
For drug screening, drugs (at dierent concentrations) were added to¯y food at 5508C and left over-night for drying. Care was taken to ensure homogenous mixing of the drug in the¯y food. Blind-tests were carried out, wherein we got the vials (with and without drugs) coded with the help of other members of the lab and the identities were revealed only after the experiments were done. The crosses were always set-up in triplicates.
Histology
RNA in situ was done essentially as described by Tautz and Pfei¯e (1989) using FB10B cDNA clone of hAPC as the probe. X-gal staining and immuno-histochemical staining were essentially as described (Ghysen and O'Kane, 1989; Patel et al., 1989) . The lacZ reporter gene constructs used are UAS-lacZ (Brand and Perrimon, 1993) and dpp-lacZ (Blackman et al., 1991) . The primary antibodies used are, antihAPC (Hayashi et al., 1997) , anti-Arm (Riggleman et al., 1990) , anti-Dll (Vachon et al., 1992) , anti-Dac (Mardon et al., 1994) and anti-Wg (Brook and . Anti-Arm and anti-Wg were obtained from the Development Studies Hybridoma Bank, University of Iowa, USA. The adult appendages were processed for microscopy as described before (Shashidhara et al., 1999) . For Scanning Electron microscopy (SEM), adult heads were air dried and coated with gold. SEM was carried out on Hitachi S520 machine.
